EZH2 copy number gain as a therapeutic target in mucosal melanoma

被引：0
|
作者：
Yu, Huan
Kong, Yan
Yan, Junya
Ma, Meng
Xu, Longwen
Yu, Jiayi
Xu, Tianxiao
Dai, Jie
Tang, Huan
Wu, Xiaowen
Chi, Zhihong
Si, Lu
Shen, Xinan
Tang, Bixia
Lian, Bin
Wang, Xuan
Li, Siming
Bai, Xue
Guo, Jun
机构：
[1] Peking Univ, Canc Hosp & Inst, Beijing, Peoples R China
[2] Peking Univ, Canc Hosp, Beijing, Peoples R China
[3] Peking Univ, Key Lab Carcinogenesis & Translat Res, Canc Hosp & Inst,Dept Renal Canc & Melanoma, Collaborat Innovat Ctr Canc Med,Minist Educ Beiji, Beijing 100142, Peoples R China
[4] Beijing Canc Hosp, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e21530
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21530
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [21] EZH2 Expression in Rhabdomyosarcoma: A Potential Biomarker and Therapeutic Target
    Wang, Qian
    Shapiro, Kate
    Lu, Yong
    Shroyer, Kenneth
    Hwang, Sonya
    LABORATORY INVESTIGATION, 2019, 99
  • [22] EZH2, a potential therapeutic target in Merkel cell carcinoma
    Durand, M.
    Mouchard, A.
    Esnault, C.
    Samimi, M.
    Kervarrec, T.
    Touze, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (10) : S191 - S191
  • [23] EZH2 presents a therapeutic target for neuroendocrine tumors of the small intestine
    Elham Barazeghi
    Per Hellman
    Olov Norlén
    Gunnar Westin
    Peter Stålberg
    Scientific Reports, 11
  • [24] EZH2 AS A NOVEL THERAPEUTIC TARGET FOR TREATMENT OF PANCREATIC DUCTAL ADENOCARCINOMA
    Avan, A.
    Paolicchi, E.
    Crea, F.
    Funel, N.
    Galvani, E.
    Marquez, V.
    Honeywell, R.
    Danesi, R.
    Peters, G. J.
    Giovannetti, E.
    ANNALS OF ONCOLOGY, 2012, 23 : 31 - 32
  • [25] Histone Methyltransferase EZH2: A Potential Therapeutic Target for Kidney Diseases
    Li, Tingting
    Yu, Chao
    Zhuang, Shougang
    FRONTIERS IN PHYSIOLOGY, 2021, 12
  • [26] EZH2 inhibitors in immunotherapy of melanoma
    Hersey, Peter
    Gallagher, Stuart
    Tiffen, Jessamy
    Shklovskaya, Elena
    Wilson, Stephen
    Filipp, Fabian
    CANCER RESEARCH, 2017, 77
  • [27] EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies
    Tremblay-LeMay, Rosemarie
    Rastgoo, Nasrin
    Pourabdollah, Maryam
    Chang, Hong
    BIOMARKER RESEARCH, 2018, 6
  • [28] EZH2 as a Novel Therapeutic Target for Atrial Fibrosis and Atrial Fibrillation
    Song, Shuai
    Wang, Qunshan
    CIRCULATION, 2019, 140
  • [29] EZH2 presents a therapeutic target for neuroendocrine tumors of the small intestine
    Barazeghi, Elham
    Hellman, Per
    Norlen, Olov
    Westin, Gunnar
    Stalberg, Peter
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [30] EZH2 as a novel therapeutic target for atrial fibrosis and atrial fibrillation
    Song, Shuai
    Zhang, Rui
    Mo, Binfeng
    Chen, Long
    Liu, Liang
    Yu, Yi
    Cao, Wei
    Fang, Guojian
    Wan, Yi
    Gu, Yue
    Wang, Yuepeng
    Li, Yigang
    Yu, Ying
    Wang, Qunshan
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2019, 135 : 119 - 133
12345